Exact Sciences Corp logo

Exact Sciences Corp

$ 39.56 -1.55 (-3.77%) 11:09 PM EST
P/E:
At Loss
P/B:
2.18
Market Cap:
$ 7.00B
Enterprise V:
$ 8.72B
Volume:
2.68M
Avg Vol (2M):
2.08M
Also Trade In:
Volume:
2.68M
Market Cap $:
7.00B
PE Ratio:
At Loss
Avg Vol (2-Month):
2.08M
Enterprise Value $:
8.72B
PB Ratio:
2.18
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Exact Sciences Corp
NAICS : 621511 SIC : 8731
5505 Endeavor Lane, Madison, WI, USA, 53719
Compare
Compare
SYNH SHC MEDP GH QGEN NTRA CRL NEOG TWST MYGN TMO DHR XSWX:LONN IQV SHSE:603259 A ILMN IDXX MTD LH
Traded in other countries / regions
EXK.Germany EXAS.USA
Description
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a non-invasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a genetic-based treatment selection test for breast, prostate, and colon cancers. With the acquisitions of Base Genomics and Thrive Earlier Detection, Exact is building a multi-cancer early screening test to detect over 14 cancers, a test that would be one of the earliest entrants in multi-cancer liquid biopsy cancer screening.
Name Current Vs Industry Vs History
Cash-To-Debt 0.3
Equity-to-Asset 0.5
Debt-to-Equity 0.76
Debt-to-EBITDA -4.51
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.7
Distress
Grey
Safe
Beneish M-Score -2.89
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 25.94
9-Day RSI 32.67
14-Day RSI 37.61
6-1 Month Momentum % -37.27
12-1 Month Momentum % -49.88

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.48
Quick Ratio 2.23
Cash Ratio 1.64
Days Inventory 73.57
Days Sales Outstanding 40.86
Days Payable 42.14

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.1

Financials (Next Earnings Date:2022-11-02 Est.)

EXAS's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:EXAS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1,938.402
EPS (TTM) ($) -4.23
Beta 1.05
Volatility % 34.06
14-Day RSI 37.61
14-Day ATR ($) 2.750719
20-Day SMA ($) 45.286
12-1 Month Momentum % -49.88
52-Week Range ($) 35.34 - 108.99
Shares Outstanding (Mil) 176.96

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Exact Sciences Corp Filings

Document Form Filing Date
No Filing Data

Headlines

See More